212 related articles for article (PubMed ID: 18221122)
1. Pharmacogenetics of statins therapy.
Puccetti L; Acampa M; Auteri A
Recent Pat Cardiovasc Drug Discov; 2007 Nov; 2(3):228-36. PubMed ID: 18221122
[TBL] [Abstract][Full Text] [Related]
2. Pharmacogenomics of statin responsiveness.
Kajinami K; Akao H; Polisecki E; Schaefer EJ
Am J Cardiol; 2005 Nov; 96(9A):65K-70K; discussion 34K-35K. PubMed ID: 16291017
[TBL] [Abstract][Full Text] [Related]
3. Pharmacogenomics of lipid-lowering therapies.
Hu M; Tomlinson B
Pharmacogenomics; 2013 Jun; 14(8):981-95. PubMed ID: 23746191
[TBL] [Abstract][Full Text] [Related]
4. Pharmacogenetics of response to statins: where do we stand?
Maitland-van der Zee AH; Boerwinkle E
Curr Atheroscler Rep; 2005 May; 7(3):204-8. PubMed ID: 15811254
[TBL] [Abstract][Full Text] [Related]
5. Pharmacogenomics of cholesterol-lowering therapy.
Schmitz G; Langmann T
Vascul Pharmacol; 2006 Feb; 44(2):75-89. PubMed ID: 16337220
[TBL] [Abstract][Full Text] [Related]
6. Impact of genetic polymorphisms on the efficacy of HMG-CoA reductase inhibitors.
Hutz MH; Fiegenbaum M
Am J Cardiovasc Drugs; 2008; 8(3):161-70. PubMed ID: 18533737
[TBL] [Abstract][Full Text] [Related]
7. Pharmacogenomics and pharmacogenetics of cholesterol-lowering therapy.
Schmitz G; Drobnik W
Clin Chem Lab Med; 2003 Apr; 41(4):581-9. PubMed ID: 12747606
[TBL] [Abstract][Full Text] [Related]
8. Genetic determinants of response to statins.
Peters BJ; Klungel OH; de Boer A; Maitland-van der Zee AH
Expert Rev Cardiovasc Ther; 2009 Aug; 7(8):977-83. PubMed ID: 19673675
[TBL] [Abstract][Full Text] [Related]
9. Genetic determinants of lipid-lowering response to atorvastatin therapy in an Indian population.
Kadam P; Ashavaid TF; Ponde CK; Rajani RM
J Clin Pharm Ther; 2016 Jun; 41(3):329-33. PubMed ID: 26932749
[TBL] [Abstract][Full Text] [Related]
10. Pharmacogenomic importance of pravastatin.
Peters B; Maitland-van der Zee AH
Pharmacogenomics; 2008 Sep; 9(9):1207-10. PubMed ID: 18781848
[TBL] [Abstract][Full Text] [Related]
11. Pharmacogenomics of statin response.
Mangravite LM; Wilke RA; Zhang J; Krauss RM
Curr Opin Mol Ther; 2008 Dec; 10(6):555-61. PubMed ID: 19051133
[TBL] [Abstract][Full Text] [Related]
12. Statin pharmacogenomics: what have we learned, and what remains unanswered?
Kajinami K; Okabayashi M; Sato R; Polisecki E; Schaefer EJ
Curr Opin Lipidol; 2005 Dec; 16(6):606-13. PubMed ID: 16276236
[TBL] [Abstract][Full Text] [Related]
13. Clinical implications of pharmacogenetic variation on the effects of statins.
Maggo SD; Kennedy MA; Clark DW
Drug Saf; 2011 Jan; 34(1):1-19. PubMed ID: 21142270
[TBL] [Abstract][Full Text] [Related]
14. Personalised medicine in hypercholesterolaemia: the role of pharmacogenetics in statin therapy.
Ahangari N; Doosti M; Ghayour Mobarhan M; Sahebkar A; Ferns GA; Pasdar A
Ann Med; 2020 Dec; 52(8):462-470. PubMed ID: 32735150
[TBL] [Abstract][Full Text] [Related]
15. Use of statins in primary and secondary prevention of coronary heart disease and ischemic stroke. Meta-analysis of randomized trials.
Vrecer M; Turk S; Drinovec J; Mrhar A
Int J Clin Pharmacol Ther; 2003 Dec; 41(12):567-77. PubMed ID: 14692706
[TBL] [Abstract][Full Text] [Related]
16. Evidence supporting primary prevention of cardiovascular diseases with statins: Gaps between updated clinical results and actual practice.
Bruckert E; Ferrières J
Arch Cardiovasc Dis; 2014 Mar; 107(3):188-200. PubMed ID: 24613429
[TBL] [Abstract][Full Text] [Related]
17. Laboratory Medicine in the Clinical Decision Support for Treatment of Hypercholesterolemia: Pharmacogenetics of Statins.
Ruaño G; Seip R; Windemuth A; Wu AH; Thompson PD
Clin Lab Med; 2016 Sep; 36(3):473-91. PubMed ID: 27514463
[TBL] [Abstract][Full Text] [Related]
18. Pharmacogenetics and pharmacogenomics of cholesterol-lowering therapy.
Schmitz G; Schmitz-Madry A; Ugocsai P
Curr Opin Lipidol; 2007 Apr; 18(2):164-73. PubMed ID: 17353665
[TBL] [Abstract][Full Text] [Related]
19. The pharmacogenomics of statins.
Gelissen IC; McLachlan AJ
Pharmacol Res; 2014 Oct; 88():99-106. PubMed ID: 24365577
[TBL] [Abstract][Full Text] [Related]
20. Pharmacogenetics of apolipoprotein E gene during lipid-lowering therapy: lipid levels and prevention of coronary heart disease.
Nieminen T; Kähönen M; Viiri LE; Grönroos P; Lehtimäki T
Pharmacogenomics; 2008 Oct; 9(10):1475-86. PubMed ID: 18855536
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
